Patients having disease-causing variants in the DNM1 gene typically reveal profound hypotonia from birth, infantile spasms that might lead to the Lennox–Gastaut syndrome, developmental delay, microcephaly (few patients), cortical visual impairment, speech delay, and intellectual disability (11, 12). This evidence concerns the gene DNM1 and Delayed speech and language development.